Baidu
map

妊娠和产后甲状腺疾病诊治指南(第2版)

2019-08-30 中国内分泌相关专家小组(统称) 中华内分泌代谢杂志.2019.35(8):636-665.

《妊娠和产后甲状腺疾病诊治指南》(第2版)是2012年指南的更新。指南新增1个章节,提出78个问题,给出66个推荐。修定了妊娠期甲状腺功能减退促甲状腺激素诊断切点值、妊娠期甲状腺功能减退和甲状腺功能亢进药物治疗等,制定了妊娠前促甲状腺激素筛查后处理流程图,旨在为临床医师对相关问题做出临床决策提供参考。

中文标题:

妊娠和产后甲状腺疾病诊治指南(第2版)

发布日期:

2019-08-30

简要介绍:

《妊娠和产后甲状腺疾病诊治指南》(第2版)是2012年指南的更新。指南新增1个章节,提出78个问题,给出66个推荐。修定了妊娠期甲状腺功能减退促甲状腺激素诊断切点值、妊娠期甲状腺功能减退和甲状腺功能亢进药物治疗等,制定了妊娠前促甲状腺激素筛查后处理流程图,旨在为临床医师对相关问题做出临床决策提供参考。

 

拓展指南:甲状腺相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=妊娠和产后甲状腺疾病诊治指南(第2版))] GetToolGuiderByIdResponse(projectId=1, id=f74381c001e9a492, title=妊娠和产后甲状腺疾病诊治指南(第2版), enTitle=, guiderFrom=中华内分泌代谢杂志.2019.35(8):636-665., authorId=null, author=, summary=《妊娠和产后甲状腺疾病诊治指南》(第2版)是2012年指南的更新。指南新增1个章节,提出78个问题,给出66个推荐。修定了妊娠期甲状腺功能减退促甲状腺激素诊断切点值、妊娠期甲状腺功能减退和甲状腺功能亢进药物治疗等,制定了妊娠前促甲状腺激素筛查后处理流程图,旨在为临床医师对相关问题做出临床决策提供参考。 , cover=, journalId=null, articlesId=null, associationId=666, associationName=中国内分泌相关专家小组(统称), associationIntro=这是一个统称,其下指南和专家共识均由国内内分泌领域的专家制定。, copyright=0, guiderPublishedTime=Fri Aug 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>《妊娠和产后甲状腺疾病诊治指南》(第2版)是2012年指南的更新。指南新增1个章节,提出78个问题,给出66个推荐。修定了妊娠期甲状腺功能减退促甲状腺激素诊断切点值、妊娠期甲状腺功能减退和甲状腺功能亢进药物治疗等,制定了妊娠前促甲状腺激素筛查后处理流程图,旨在为临床医师对相关问题做出临床决策提供参考。 </P> <P> </P>拓展指南:<strong>与<font color=red>甲状腺</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=081b31c001e901b7" title="2019 EANM实践指南:PET/CT检查甲状腺髓样癌" target=_blank>2019 EANM实践指南:PET/CT检查甲状腺髓样癌</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=53e351c001e683f2" title="碘难治性分化型甲状腺癌的诊治管理共识(2019年版)" target=_blank>碘难治性分化型甲状腺癌的诊治管理共识(2019年版)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=af9b11c001e50089" title="2019 ACR适宜性标准:甲状腺疾病" target=_blank>2019 ACR适宜性标准:甲状腺疾病</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=2c1341c001e3507e" title="2018 CSCO临床指南:持续/复发及转移性分化型甲状腺癌的诊断和治疗(英文版)" target=_blank>2018 CSCO临床指南:持续/复发及转移性分化型甲状腺癌的诊断和治疗(英文版)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=c2a5e1c001e302ab" title="NCCN临床实践指南:甲状腺癌(2019.V1)" target=_blank>NCCN临床实践指南:甲状腺癌(2019.V1)</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E7%94%B2%E7%8A%B6%E8%85%BA" target=_blank>有关甲状腺更多指南</a></ul>, tagList=[TagDto(tagId=94720, tagName=妊娠和产后甲状腺疾病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8997, appHits=1816, showAppHits=79, pcHits=4148, showPcHits=4524, likes=124, shares=121, comments=40, approvalStatus=1, publishedTime=Sun Sep 22 22:43:41 CST 2019, publishedTimeString=2019-08-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Sep 22 22:43:41 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 22:19:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=妊娠和产后甲状腺疾病诊治指南(第2版))])
妊娠和产后甲状腺疾病诊治指南(第2版)
下载请点击:
评论区 (35)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1055749, encodeId=f5f31055e492a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42001695310, createdName=wenbo, createdTime=Tue Sep 28 16:52:08 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051146, encodeId=996c105114609, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7dd05602726, createdName=ms6000001696729929, createdTime=Tue Sep 14 15:47:13 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051145, encodeId=9ed81051145a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7dd05602726, createdName=ms6000001696729929, createdTime=Tue Sep 14 15:46:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006219, encodeId=375c100621940, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210719/b39bdf9a041544b999297bf2fca2a2f6/176d9e957fa04e58a780cbf040856330.jpg, createdBy=ddff5552050, createdName=马上行动吧, createdTime=Mon Aug 09 08:11:06 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002466, encodeId=ebb11002466e3, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210725/fbf656226b804325993f4fb0dd0ba8bc/5759e04b66a1400ca1f820d0146b919b.jpg, createdBy=a86a5556350, createdName=ms9000001055043657, createdTime=Sun Jul 25 11:22:04 CST 2021, time=2021-07-25, status=1, ipAttribution=)]
    2021-09-28 wenbo

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1055749, encodeId=f5f31055e492a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42001695310, createdName=wenbo, createdTime=Tue Sep 28 16:52:08 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051146, encodeId=996c105114609, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7dd05602726, createdName=ms6000001696729929, createdTime=Tue Sep 14 15:47:13 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051145, encodeId=9ed81051145a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7dd05602726, createdName=ms6000001696729929, createdTime=Tue Sep 14 15:46:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006219, encodeId=375c100621940, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210719/b39bdf9a041544b999297bf2fca2a2f6/176d9e957fa04e58a780cbf040856330.jpg, createdBy=ddff5552050, createdName=马上行动吧, createdTime=Mon Aug 09 08:11:06 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002466, encodeId=ebb11002466e3, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210725/fbf656226b804325993f4fb0dd0ba8bc/5759e04b66a1400ca1f820d0146b919b.jpg, createdBy=a86a5556350, createdName=ms9000001055043657, createdTime=Sun Jul 25 11:22:04 CST 2021, time=2021-07-25, status=1, ipAttribution=)]
    2021-09-14 ms6000001696729929

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1055749, encodeId=f5f31055e492a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42001695310, createdName=wenbo, createdTime=Tue Sep 28 16:52:08 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051146, encodeId=996c105114609, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7dd05602726, createdName=ms6000001696729929, createdTime=Tue Sep 14 15:47:13 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051145, encodeId=9ed81051145a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7dd05602726, createdName=ms6000001696729929, createdTime=Tue Sep 14 15:46:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006219, encodeId=375c100621940, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210719/b39bdf9a041544b999297bf2fca2a2f6/176d9e957fa04e58a780cbf040856330.jpg, createdBy=ddff5552050, createdName=马上行动吧, createdTime=Mon Aug 09 08:11:06 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002466, encodeId=ebb11002466e3, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210725/fbf656226b804325993f4fb0dd0ba8bc/5759e04b66a1400ca1f820d0146b919b.jpg, createdBy=a86a5556350, createdName=ms9000001055043657, createdTime=Sun Jul 25 11:22:04 CST 2021, time=2021-07-25, status=1, ipAttribution=)]
    2021-09-14 ms6000001696729929

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1055749, encodeId=f5f31055e492a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42001695310, createdName=wenbo, createdTime=Tue Sep 28 16:52:08 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051146, encodeId=996c105114609, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7dd05602726, createdName=ms6000001696729929, createdTime=Tue Sep 14 15:47:13 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051145, encodeId=9ed81051145a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7dd05602726, createdName=ms6000001696729929, createdTime=Tue Sep 14 15:46:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006219, encodeId=375c100621940, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210719/b39bdf9a041544b999297bf2fca2a2f6/176d9e957fa04e58a780cbf040856330.jpg, createdBy=ddff5552050, createdName=马上行动吧, createdTime=Mon Aug 09 08:11:06 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002466, encodeId=ebb11002466e3, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210725/fbf656226b804325993f4fb0dd0ba8bc/5759e04b66a1400ca1f820d0146b919b.jpg, createdBy=a86a5556350, createdName=ms9000001055043657, createdTime=Sun Jul 25 11:22:04 CST 2021, time=2021-07-25, status=1, ipAttribution=)]
    2021-08-09 马上行动吧

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1055749, encodeId=f5f31055e492a, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=42001695310, createdName=wenbo, createdTime=Tue Sep 28 16:52:08 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051146, encodeId=996c105114609, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7dd05602726, createdName=ms6000001696729929, createdTime=Tue Sep 14 15:47:13 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051145, encodeId=9ed81051145a0, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7dd05602726, createdName=ms6000001696729929, createdTime=Tue Sep 14 15:46:46 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006219, encodeId=375c100621940, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210719/b39bdf9a041544b999297bf2fca2a2f6/176d9e957fa04e58a780cbf040856330.jpg, createdBy=ddff5552050, createdName=马上行动吧, createdTime=Mon Aug 09 08:11:06 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002466, encodeId=ebb11002466e3, content=学习了<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210725/fbf656226b804325993f4fb0dd0ba8bc/5759e04b66a1400ca1f820d0146b919b.jpg, createdBy=a86a5556350, createdName=ms9000001055043657, createdTime=Sun Jul 25 11:22:04 CST 2021, time=2021-07-25, status=1, ipAttribution=)]
    2021-07-25 ms9000001055043657

    学习了#学习#

    0

Baidu
map
Baidu
map
Baidu
map